TY  - JOUR

T1  - Phase II trial of dose-dense BEP for intermediate- and poor-prognosis metastatic germ cell tumors.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2010.28.15_suppl.e15011

PY  - 2010/05/20

AU  - Rimmer YL

AU  - Chester JD

AU  - Stark DP

AU  - Joffe JK

AU  - Shamash J

AU  - White JD

AU  - Upton N

AU  - Wason J

AU  - Parashar D

AU  - Williams MV

ED  - 

DO  - DOI: 10.1200/jco.2010.28.15_suppl.e15011

PB  - American Society of Clinical Oncology (ASCO)

VL  - 28

IS  - 15_suppl

SP  - e15011

EP  - e15011

Y2  - 2026/10/28

ER  -